Which medications in the drug class Antirheumatic, Disease Modifying are used in the treatment of Exfoliative Dermatitis?

Updated: Jun 22, 2021
  • Author: David Vearrier, MD, MPH; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print

Antirheumatic, Disease Modifying

These agents modulate inflammatory and immune responses.

Etanercept (Enbrel)

Etanercept is a soluble p75 TNF receptor fusion protein (sTNFR-Ig). It inhibits TNF binding to cell surface receptors, which, in turn, decreases inflammatory and immune responses. It has been reported to be effective. There is no current FDA approval/indication for the use of this drug with exfoliative dermatitis.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!